Integrated Corporate Solutions, 37 Harvest View Drive, Monroe 08831; 609-448-0886; fax, 609-448-3625. Carl DeWorsop, president.
Printer cartridges are a big expense, largely because they have to be re-ordered so often.
Part of the reason is that printer cartridges have gotten smaller than a pack of cigarettes, compared to the postcard-sized cartridges that abounded a few years ago.
But another reason, says Carl DeWorsop, owner of Integrated Corporate Solutions, which just merged with Cartridge World, DeWorsop’s sister business in Hamilton, is that people might not print enough.
Water-based inks are the norm today, DeWorsop says. Consequently, without regular use, cartridges simply dry up.
“You should print out at least a test page a week,” he says.
Extended life cartridges, which hold more ink and cost nearly double, are not necessarily a better deal, he says, and are no deal at all if you don’t do regular printing to keep the inks wet.
Regardless, he recommends laser jet printers because they do not dry out.
ICS, which has six employees, refills cartridges — a process that not only saves spent cartridges from the landfill but shaves as much as 50 percent off the cost of a new cartridge,
DeWorsop says. But refilling cartridges yourself is hardly worth it.
“It’s a pain in the butt even if you have the right equipment,” he says.
Nucleus Holdings, 300 American Metro Boulevard, Suite 130, Hamilton 08619; 609-981-4001; fax, 609-981-4202. Tanya Brinsden, vice president. Home page: www.meditechmedia.com.
Nucleus Holdings, an events and media planning agency catering to the pharmaceutical industry, has moved from Carnegie Center to American Metro Center in Hamilton.
The company’s new address allows for more space for its growing staff. It is the only shareholder in an international group of companies (the Nucleus Group) whose key mission is to provide educational and marketing solutions for a diverse range of healthcare communication needs
Last year the company reported 20 employees at its Carnegie Center office. This year Nucleus employs 30.
A division of MediTech Media, the Westwood, Massachusetts-based provider of software and information for the healthcare industry, Nucleus has offices in Asia, Australia, Europe, and other parts of the United States.
Johnson & Johnson Pharmaceutical and Development Inc., 8 Clarke Drive, Cedar Brook Corporate Center, Cranbury 08512; 609-655-6900; fax, 609-655-6930.
Johnson & Johnson has closed its pharmaceutical R&D facility on Cedar Brook Drive in Cranbury and relocated the office to Spring Hill, Pennsylvania.
According to the company, the move is a realignment, as all 15 employees from the Cranbury site have been relocated. All inquiries regarding the company may be sent to: JNJ.Com, Box 726, Langhorne, PA 19047-0726.
Stage Depot Inn, Pennington-Rocky Hill Road, Pennington 08534; 609-466-2000. Steven Friedman, manager.
The Stage Depot Inn, the only hotel in Pennington, located in Pennytown Village, has closed. The number was disconnected and owner Steven Friedman could not be reached for comment.
Covance Inc. (CVD), 206 Carnegie Center, Princeton 08540-6681; 609-452-8550; fax, 609-452-9375. Joe Herring, CEO. Home page: www.covance.com.
Covance Inc. has announced that Steven M. Michael has joined the company as vice president and chief scientific officer of global bioanalytical services.
With 15 years of pharmaceutical industry experience, including bioanalytical research, translational research, and talent development, Michael will lead scientific, marketing, and business development strategy for Covance’s bioanalytical services.
Michael joins Covance from Pfizer Global Research and Development where he served as executive director of bioanalytical research in Worldwide Pharmacokinetics, Dynamics & Metabolism. As a member of the executive leadership team, he provided strategic leadership for the Worldwide Pharmacokinetics, Dynamics & Metabolism group and led the regulated bioanalytical support of the Pfizer human health portfolio. Michael’s experience also includes drug discovery, drug development, and research technology with focus on bioanalytical research, translational research, biomarkers, and leadership development.
Michael received a doctorate in analytical chemistry from the University of Michigan. He is a member of the American Society of Mass Spectrometry and the American Association of Pharmaceutical Scientists and has been published in various scientific publications.
Offering global flexible capacity and more than 350 bioanalytical scientists with more than 2,600 years of combined industry experience, Covance’s bioanalytical services group develops and validates more than 550 methods every year to support drug development from discovery through Phase IV.
New in Town
William T. Harvey, 3371 Brunswick Pike, Lawrence Commons, Suite 215, Lawrenceville 08648; 609-843-0505; fax, 609-482-3673. http://wthlegal.intuitwebsites.com.
Attorney William T. Harvey has opened a practice on Brunswick Pike in Lawrenceville.
A 2001 graduate of Montclair State University, Harvey earned his J.D. from New York Law School in 2005. He practices personal injury law, law for business organizations, estate planning and probate, real estate law, and debt collection.
PeriGen (CBG), 700 Alexander Park, Suite 100, Princeton 08540; 212-686-1530; fax, 212-686-1532. Donald Deieso, CEO. Home page: www.ecmed.net.
PeriGen, a company that uses technology to give physicians warning of complications in their maternity patients, has partnered with AirStrip Technologies, a San Antonio-based company that delivers critical patient information to doctors and nurses via smartphones.
“This partnership unites PeriGen’s clinical decision support system with AirStrip’s remote surveillance technology to keep clinicians informed of a patient’s current condition,” Donald A. Deieso, PeriGen chairman and CEO, said in a prepared statement. “Whether they are near to or far from the bedside, doctors will now be able to view critical medical data on a mobile device.”
Ranbaxy Inc., 600 College Road East, Suite 2100, Princeton 08540; 609-720-9200; fax, 609-720-1155. Dipak Chattaraj, president. Home page: www.ranbaxyusa.com.
The Princeton-based U.S. subsidiary of Ranbaxy Laboratories, the largest India-based drug maker, has voluntarily recalled a single batch of skin infection drug Sotret Isotretinoin capsules of 40mg strength from the U.S. market.
According to the company, the recall is limited to lot No. 1876846.
A company official said that the recall is considered a Class III recall, which, according to the FDA, implies that the use of or exposure to the product is not likely to cause adverse health consequences.
Still the full reason the company recalled the batch is not known. Ranbaxy tested the lot in question and reported it to be “in conformity with the requisite product specifications.” The recall was said by the company to be due to “an abundance of caution.”
Ranbaxy got FDA approval to market Sotret in 2003. The drug generates $415 million in revenues a year.
Earlier this year Ranbaxy voluntarily recalled the urinary tract infection drug Nitrofurantoin from the US market after it was found that the drugs did not meet the US drug manufacturing standards.
Karen Imparata Cotton, 58, on July 14. An animal welfare advocate, she campaigned for non-lethal solutions to Princeton’s deer overpopulation issue and was on the board of the International Fund for Animal Welfare. She was instrumental in the inclusion of bird safety standards for LEED Green Building certification.
Mary Beth Farina, 54, on July 16. She was a software developer for Princeton Imaging in Research Park.